Russell Investments Group Ltd. acquired a new stake in shares of OptimizeRx Co. (OTCMKTS:OPRX) in the 3rd quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor acquired 85,282 shares of the technology company’s stock, valued at approximately $1,535,000. Russell Investments Group Ltd. owned about 0.73% of OptimizeRx at the end of the most recent quarter.
Several other large investors have also recently modified their holdings of the company. MAI Capital Management bought a new position in OptimizeRx in the second quarter worth about $139,000. Family Management Corp bought a new position in OptimizeRx in the second quarter worth about $184,000. Granite Investment Partners LLC bought a new position in OptimizeRx in the second quarter worth about $478,000. Finally, Wolverine Asset Management LLC bought a new position in OptimizeRx in the second quarter worth about $7,745,000. 0.35% of the stock is owned by hedge funds and other institutional investors.
Shares of OPRX opened at $15.00 on Friday. OptimizeRx Co. has a fifty-two week low of $2.30 and a fifty-two week high of $18.39.
OptimizeRx (OTCMKTS:OPRX) last posted its quarterly earnings results on Monday, November 5th. The technology company reported $0.02 EPS for the quarter, beating the Zacks’ consensus estimate of $0.01 by $0.01. The firm had revenue of $5.42 million for the quarter, compared to analysts’ expectations of $5.28 million.
A number of research firms recently issued reports on OPRX. Zacks Investment Research downgraded shares of OptimizeRx from a “strong-buy” rating to a “hold” rating in a research note on Wednesday, October 10th. Lake Street Capital upped their price objective on shares of OptimizeRx to $18.00 and gave the stock a “buy” rating in a report on Monday, September 17th.
COPYRIGHT VIOLATION WARNING: This piece of content was originally posted by Dispatch Tribunal and is the property of of Dispatch Tribunal. If you are viewing this piece of content on another website, it was stolen and republished in violation of international copyright and trademark laws. The correct version of this piece of content can be read at https://www.dispatchtribunal.com/2018/12/07/russell-investments-group-ltd-acquires-new-position-in-optimizerx-co-oprx.html.
OptimizeRx Corporation provides digital health messaging to the pharmaceutical industry. The company offers a direct channel for pharmaceutical companies to communicate with healthcare providers. Its products and applications include financial messaging, a virtual patient support center that allows doctors and staff to access sample vouchers, co-pay coupons, and other patient support through their EMR and/or e-Prescribe systems to search, print, or electronically dispense directly to patients, as well as a network of pharmacies; and brand messaging services, such as various brand awareness and clinical messaging services consisting of brand awareness messages, reminder ads, clinical messages, and unbranded messages that could be targeted by specialty, diagnostic code, and other criteria.
Featured Article: Bear Market
Receive News & Ratings for OptimizeRx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for OptimizeRx and related companies with MarketBeat.com's FREE daily email newsletter.